Document and Entity Information
Document and Entity Information - shares | 9 Months Ended | |
Sep. 30, 2019 | Oct. 31, 2019 | |
Cover page. | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Sep. 30, 2019 | |
Document Transition Report | false | |
Entity File Number | 1-13270 | |
Entity Incorporation, State or Country Code | DE | |
Entity Tax Identification Number | 90-0023731 | |
Entity Address, Address Line One | 10603 W. Sam Houston Parkway N. | |
Entity Address, Address Line Two | Suite 300 | |
Entity Address, City or Town | Houston, | |
Entity Address, State or Province | TX | |
Entity Address, Postal Zip Code | 77064 | |
City Area Code | 713 | |
Local Phone Number | 849-9911 | |
Title of 12(b) security | Common Stock, $0.0001 par value | |
Trading symbol | FTK | |
Security exchange name | NYSE | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Accelerated Filer | |
Entity Small Business | true | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding | 57,794,676 | |
Entity Registrant Name | FLOTEK INDUSTRIES INC/CN | |
Entity Central Index Key | 0000928054 | |
Current Fiscal Year End Date | --12-31 | |
Document Fiscal Year Focus | 2019 | |
Document Fiscal Period Focus | Q3 | |
Amendment Flag | false |
Unaudited Condensed Consolidate
Unaudited Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Sep. 30, 2019 | Dec. 31, 2018 |
Current assets: | ||
Cash and cash equivalents | $ 106,994 | $ 3,044 |
Restricted cash | 663 | 0 |
Accounts receivable, net of allowance for doubtful accounts of $1,520 and $1,190 at September 30, 2019 and December 31, 2018, respectively | 15,014 | 37,047 |
Inventories, net | 24,333 | 27,289 |
Income taxes receivable | 313 | 3,161 |
Assets held for sale | 0 | 118,470 |
Other current assets | 19,181 | 5,771 |
Total current assets | 166,498 | 194,782 |
Property and equipment, net | 41,180 | 45,485 |
Operating lease right-of-use assets | 17,625 | |
Deferred tax assets, net | 476 | 18,663 |
Other intangible assets, net | 23,578 | 26,827 |
Other long-term assets | 0 | 126 |
TOTAL ASSETS | 249,357 | 285,883 |
Current liabilities: | ||
Accounts payable | 10,578 | 15,011 |
Accrued liabilities | 7,797 | 10,335 |
Income taxes payable | 276 | 0 |
Interest payable | 0 | 8 |
Liabilities held for sale | 0 | 9,174 |
Current portion of lease liabilities | 762 | |
Long-term debt, classified as current | 0 | 49,731 |
Total current liabilities | 19,413 | 84,259 |
Long-term operating lease liabilities | 17,945 | |
Long-term finance lease liabilities | 172 | |
Deferred tax liabilities, net | 116 | 0 |
Total liabilities | 37,646 | 84,259 |
Commitments and contingencies | ||
Stockholders’ equity: | ||
Preferred stock, $0.0001 par value, 100,000 shares authorized; no shares issued and outstanding | 0 | 0 |
Common stock, $0.0001 par value, 80,000,000 shares authorized; 63,038,397 shares issued and 58,909,280 shares outstanding at September 30, 2019; 62,162,875 shares issued and 57,342,279 shares outstanding at December 31, 2018 | 6 | 6 |
Additional paid-in capital | 346,392 | 343,536 |
Accumulated other comprehensive loss | (962) | (1,116) |
Retained earnings (accumulated deficit) | (100,281) | (107,565) |
Treasury stock, at cost; 4,129,117 and 3,770,224 shares at September 30, 2019 and December 31, 2018, respectively | (33,444) | (33,237) |
Total stockholders’ equity | 211,711 | 201,624 |
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $ 249,357 | $ 285,883 |
Unaudited Condensed Consolida_2
Unaudited Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands | Sep. 30, 2019 | Dec. 31, 2018 |
Statement of Financial Position [Abstract] | ||
Accounts receivable, allowance for doubtful accounts | $ 1,520 | $ 1,190 |
Preferred stock, at par value (in dollars per share) | $ 0.0001 | $ 0.0001 |
Preferred stock, shares authorized (in shares) | 100,000 | 100,000 |
Preferred stock, shares issued (in shares) | 0 | 0 |
Preferred stock, shares outstanding (in shares) | 0 | 0 |
Common stock, par value (in dollars per share) | $ 0.0001 | $ 0.0001 |
Common stock, shares authorized (in shares) | 80,000,000 | 80,000,000 |
Common stock, shares issued (in shares) | 63,038,397 | 62,162,875 |
Common stock, shares outstanding (in shares) | 58,909,280 | 57,342,279 |
Treasury stock, shares (in shares) | 4,129,117 | 3,770,224 |
Unaudited Condensed Consolida_3
Unaudited Condensed Consolidated Statements of Operations - USD ($) shares in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2019 | Sep. 30, 2018 | Sep. 30, 2019 | Sep. 30, 2018 | |
Income Statement [Abstract] | ||||
Revenue | $ 21,879,000 | $ 53,709,000 | $ 99,827,000 | $ 134,324,000 |
Costs and expenses: | ||||
Operating expenses (excluding depreciation and amortization) | 23,689,000 | 45,647,000 | 106,593,000 | 117,848,000 |
Corporate general and administrative | 5,685,000 | 7,476,000 | 19,020,000 | 24,634,000 |
Depreciation and amortization | 2,058,000 | 2,259,000 | 6,437,000 | 6,935,000 |
Research and development | 2,297,000 | 2,350,000 | 6,657,000 | 8,054,000 |
Loss on disposal of long-lived assets | 3,000 | 57,000 | 1,096,000 | 119,000 |
Impairment of goodwill | 0 | 0 | 0 | 37,180,000 |
Total costs and expenses | 33,732,000 | 57,789,000 | 139,803,000 | 194,770,000 |
Loss from operations | (11,853,000) | (4,080,000) | (39,976,000) | (60,446,000) |
Other (expense) income: | ||||
Interest expense | (1,000) | (746,000) | (2,014,000) | (1,902,000) |
Loss on sale of business | 0 | (360,000) | 0 | (360,000) |
Loss on write-down of assets held for sale | 0 | 0 | 0 | (2,580,000) |
Other income (expense), net | 436,000 | 10,000 | 1,236,000 | (2,599,000) |
Total other income (expense) | 435,000 | (1,096,000) | (778,000) | (7,441,000) |
Loss before income taxes | (11,418,000) | (5,176,000) | (40,754,000) | (67,887,000) |
Income tax benefit (expense) | 191,000 | 333,000 | 1,157,000 | (15,545,000) |
Loss from continuing operations | (11,227,000) | (4,843,000) | (39,597,000) | (83,432,000) |
Income from discontinued operations, net of tax | 117,000 | 911,000 | 46,881,000 | 4,176,000 |
Net income (loss) | (11,110,000) | (3,932,000) | 7,284,000 | (79,256,000) |
Net loss attributable to noncontrolling interests | 0 | 0 | 0 | 357,000 |
Net income (loss) attributable to Flotek Industries, Inc. (Flotek) | (11,110,000) | (3,932,000) | 7,284,000 | (78,899,000) |
Amounts attributable to Flotek shareholders: | ||||
Loss from continuing operations | (11,227,000) | (4,843,000) | (39,597,000) | (83,075,000) |
Income from discontinued operations, net of tax | 117,000 | 911,000 | 46,881,000 | 4,176,000 |
Net income (loss) attributable to Flotek Industries, Inc. (Flotek) | $ (11,110,000) | $ (3,932,000) | $ 7,284,000 | $ (78,899,000) |
Basic earnings (loss) per common share: | ||||
Continuing operations (in dollars per share) | $ (0.19) | $ (0.08) | $ (0.67) | $ (1.44) |
Discontinued operations, net of tax (in dollars per share) | 0 | 0.02 | 0.80 | 0.07 |
Basic earnings (loss) per common share (in dollars per share) | (0.19) | (0.06) | 0.13 | (1.37) |
Diluted earnings (loss) per common share: | ||||
Continuing operations (in dollars per share) | (0.19) | (0.08) | (0.67) | (1.44) |
Discontinued operations, net of tax (in dollars per share) | 0 | 0.02 | 0.80 | 0.07 |
Diluted earnings (loss) per common share (in dollars per share) | $ (0.19) | $ (0.06) | $ 0.13 | $ (1.37) |
Weighted average common shares: | ||||
Weighted average common shares used in computing basic earnings (loss) per common share (in shares) | 59,004 | 58,319 | 58,725 | 57,820 |
Weighted average common shares used in computing diluted earnings (loss) per common share (in shares) | 59,004 | 58,319 | 58,725 | 57,820 |
Unaudited Condensed Consolida_4
Unaudited Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2019 | Sep. 30, 2018 | Sep. 30, 2019 | Sep. 30, 2018 | |
Statement of Comprehensive Income [Abstract] | ||||
Loss from continuing operations | $ (11,227) | $ (4,843) | $ (39,597) | $ (83,432) |
Income from discontinued operations, net of tax | 117 | 911 | 46,881 | 4,176 |
Net income (loss) | (11,110) | (3,932) | 7,284 | (79,256) |
Other comprehensive income (loss): | ||||
Foreign currency translation adjustment | 36 | 85 | 154 | (76) |
Comprehensive income (loss) | (11,074) | (3,847) | 7,438 | (79,332) |
Net loss attributable to noncontrolling interests | 0 | 0 | 0 | 357 |
Comprehensive income (loss) attributable to Flotek | $ (11,074) | $ (3,847) | $ 7,438 | $ (78,975) |
Unaudited Condensed Consolida_5
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($) | 3 Months Ended | 9 Months Ended | |
Sep. 30, 2019 | Sep. 30, 2019 | Sep. 30, 2018 | |
Cash flows from operating activities: | |||
Net income (loss) attributable to Flotek Industries, Inc. (Flotek) | $ (11,110,000) | $ 7,284,000 | $ (78,899,000) |
Less: Income from discontinued operations, net of tax | 117,000 | 46,881,000 | 4,176,000 |
Loss from continuing operations | (11,227,000) | (39,597,000) | (83,075,000) |
Adjustments to reconcile loss from continuing operations to net cash used in operating activities: | |||
Depreciation and amortization | 2,058,000 | 6,437,000 | 6,935,000 |
Amortization of deferred financing costs | 0 | 1,428,000 | 294,000 |
Provision for doubtful accounts | 426,000 | 176,000 | |
Provision for excess and obsolete inventory | 0 | 1,817,000 | |
Impairment of goodwill | 0 | 0 | 37,180,000 |
Loss on sale of business | 0 | 0 | (360,000) |
Loss on write-down of assets held for sale | 0 | 0 | 2,580,000 |
Loss on disposal of long-lived assets | 1,096,000 | 119,000 | |
Non-cash lease expense | 813,000 | ||
Stock compensation expense | 2,829,000 | 6,594,000 | |
Deferred income tax provision | 17,983,000 | 15,358,000 | |
Reduction in tax benefit related to share-based awards | 24,000 | 312,000 | |
Changes in current assets and liabilities: | |||
Restricted cash | (663,000) | 0 | |
Accounts receivable, net | 21,629,000 | (10,392,000) | |
Inventories, net | 3,000,000 | (1,490,000) | |
Income taxes receivable | 2,853,000 | 58,000 | |
Other current assets | (14,974,000) | 1,759,000 | |
Accounts payable | (4,434,000) | 5,672,000 | |
Accrued liabilities | (13,122,000) | (9,001,000) | |
Income taxes payable | 595,000 | 0 | |
Interest payable | (8,000) | (37,000) | |
Net cash used in operating activities | (13,685,000) | (24,781,000) | |
Cash flows from investing activities: | |||
Capital expenditures | (1,869,000) | (3,965,000) | |
Proceeds from sale of business | 169,722,000 | 1,665,000 | |
Proceeds from sale of assets | 234,000 | 361,000 | |
Purchase of patents and other intangible assets | (590,000) | (1,466,000) | |
Net cash (used in) provided by investing activities | 167,497,000 | (3,405,000) | |
Cash flows from financing activities: | |||
Borrowings on revolving credit facility | 42,984,000 | 213,612,000 | |
Repayments on revolving credit facility | (92,715,000) | (188,160,000) | |
Debt issuance costs | 0 | (98,000) | |
Purchase of treasury stock related to share-based awards | (207,000) | (91,000) | |
Proceeds from sale of common stock | 7,000 | 341,000 | |
Payments for finance leases | 6,000 | 51,000 | |
Loss from noncontrolling interest | 0 | (357,000) | |
Net cash (used in) provided by financing activities | (49,880,000) | 25,247,000 | |
Discontinued operations: | |||
Net cash (used in) provided by operating activities | (321,000) | 880,000 | |
Net cash (used in) provided by investing activities | 337,000 | (630,000) | |
Net cash flows provided by discontinued operations | 16,000 | 250,000 | |
Effect of changes in exchange rates on cash and cash equivalents | 2,000 | (66,000) | |
Net increase (decrease) in cash and cash equivalents | 103,950,000 | (2,755,000) | |
Cash and cash equivalents at the beginning of period | 3,044,000 | 4,584,000 | |
Cash and cash equivalents at the end of period | $ 106,994,000 | $ 106,994,000 | $ 1,829,000 |
Unaudited Condensed Consolida_6
Unaudited Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands | Total | Common Stock | Treasury Stock | Additional Paid-in Capital | Accumulated Other Comprehensive Income (Loss) | Retained Earnings (Accumulated Deficit) | Non-controlling Interests |
Beginning balance (in shares) at Dec. 31, 2017 | (60,623,000) | 3,621,000 | |||||
Beginning balance at Dec. 31, 2017 | $ 265,258 | $ 6 | $ (33,064) | $ 336,067 | $ (884) | $ (37,225) | $ 358 |
Increase (Decrease) in Equity [Roll Forward] | |||||||
Net income (loss) | (79,256) | (78,899) | (357) | ||||
Foreign currency translation adjustment | (76) | (76) | |||||
Stock issued under employee stock purchase plan (in shares) | (111,000) | ||||||
Stock issued under employee stock purchase plan | 341 | 341 | |||||
Restricted stock granted (in shares) | 1,480,000 | ||||||
Restricted stock forfeited (in shares) | 45,000 | ||||||
Treasury stock purchased (in shares) | 29,000 | ||||||
Treasury stock purchased | (91) | $ (91) | |||||
Stock compensation expense | 6,640 | 6,640 | |||||
Ending balance (in shares) at Sep. 30, 2018 | (62,103,000) | 3,584,000 | |||||
Ending balance at Sep. 30, 2018 | 192,816 | $ 6 | $ (33,155) | 343,048 | (960) | (116,124) | 1 |
Beginning balance (in shares) at Jun. 30, 2018 | (61,642,000) | (3,607,000) | |||||
Beginning balance at Jun. 30, 2018 | 194,300 | $ 6 | $ (33,088) | 340,618 | (1,045) | (112,192) | 1 |
Increase (Decrease) in Equity [Roll Forward] | |||||||
Net income (loss) | (3,932) | (3,932) | 0 | ||||
Foreign currency translation adjustment | 85 | 85 | |||||
Stock issued under employee stock purchase plan (in shares) | (46,000) | ||||||
Stock issued under employee stock purchase plan | 94 | 94 | |||||
Restricted stock granted (in shares) | 461,000 | ||||||
Restricted stock forfeited (in shares) | 0 | ||||||
Treasury stock purchased (in shares) | 23,000 | ||||||
Treasury stock purchased | (67) | $ (67) | |||||
Stock compensation expense | 2,336 | 2,336 | |||||
Ending balance (in shares) at Sep. 30, 2018 | (62,103,000) | 3,584,000 | |||||
Ending balance at Sep. 30, 2018 | 192,816 | $ 6 | $ (33,155) | 343,048 | (960) | (116,124) | 1 |
Beginning balance (in shares) at Dec. 31, 2018 | (62,163,000) | 3,770,000 | |||||
Beginning balance at Dec. 31, 2018 | 201,624 | $ 6 | $ (33,237) | 343,536 | (1,116) | (107,565) | 0 |
Increase (Decrease) in Equity [Roll Forward] | |||||||
Net income (loss) | 7,284 | 7,284 | |||||
Foreign currency translation adjustment | 154 | 154 | |||||
Stock issued under employee stock purchase plan (in shares) | (7,000) | ||||||
Stock issued under employee stock purchase plan | $ 15 | 15 | |||||
Restricted stock granted (in shares) | 875,522 | 875,000 | |||||
Restricted stock forfeited (in shares) | 292,000 | ||||||
Treasury stock purchased (in shares) | 74,000 | ||||||
Treasury stock purchased | $ (207) | $ (207) | |||||
Stock compensation expense | 2,841 | 2,841 | |||||
Ending balance (in shares) at Sep. 30, 2019 | (63,038,000) | 4,129,000 | |||||
Ending balance at Sep. 30, 2019 | 211,711 | $ 6 | $ (33,444) | 346,392 | (962) | (100,281) | 0 |
Beginning balance (in shares) at Jun. 30, 2019 | (62,956,000) | 3,948,000 | |||||
Beginning balance at Jun. 30, 2019 | 221,676 | $ 6 | $ (33,378) | 345,217 | (998) | (89,171) | 0 |
Increase (Decrease) in Equity [Roll Forward] | |||||||
Net income (loss) | (11,110) | (11,110) | |||||
Foreign currency translation adjustment | 36 | 36 | |||||
Stock issued under employee stock purchase plan (in shares) | (8,000) | ||||||
Stock issued under employee stock purchase plan | 15 | 15 | |||||
Restricted stock granted (in shares) | 82,000 | ||||||
Restricted stock forfeited (in shares) | 159,000 | ||||||
Treasury stock purchased (in shares) | 30,000 | ||||||
Treasury stock purchased | (66) | $ (66) | |||||
Stock compensation expense | 1,160 | 1,160 | |||||
Ending balance (in shares) at Sep. 30, 2019 | (63,038,000) | 4,129,000 | |||||
Ending balance at Sep. 30, 2019 | $ 211,711 | $ 6 | $ (33,444) | $ 346,392 | $ (962) | $ (100,281) | $ 0 |
Organization and Significant Ac
Organization and Significant Accounting Policies | 9 Months Ended |
Sep. 30, 2019 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Organization and significant accounting policies | Organization and Significant Accounting Policies Organization and Nature of Operations Flotek Industries, Inc. (“Flotek” or the “Company”) is an international energy chemistry technology-driven company that develops and supplies chemistry and services to the oil and gas industry. Flotek also supplied high value compounds to companies that make food and beverages, cleaning products, cosmetics, and other products that are sold in consumer and industrial markets, which was classified as discontinued operations at December 31, 2018. The Company’s oilfield business designs, develops, manufactures, packages, distributes, delivers, and markets reservoir-centric fluid systems, including specialty and conventional chemistries, for use in oil and gas (“O&G”) well drilling, cementing, completion, remediation, and stimulation activities designed to maximize recovery in both new and mature fields. Activities in this segment also include construction and management of automated material handling facilities as well as management of loading facilities and blending operations for oilfield services companies. In the segment reported as discontinued operations at December 31, 2018, the Company processed citrus oil to produce (1) high value compounds used as additives by companies in the flavors and fragrances markets and (2) environmentally friendly chemistries for use in numerous industries around the world, including the O&G industry. Flotek operates in over 15 domestic and international markets. Customers include major integrated O&G companies, oilfield services companies, independent O&G companies, pressure-pumping service companies, national and state-owned oil companies, and international supply chain management companies. The Company also served customers who purchase non-energy-related citrus oil and related products, including household and commercial cleaning product companies, fragrance and cosmetic companies, and food manufacturing companies, reported as discontinued operations at December 31, 2018. Flotek was initially incorporated under the laws of the Province of British Columbia on May 17, 1985. On October 23, 2001, Flotek changed its corporate domicile to the state of Delaware. Basis of Presentation The accompanying Unaudited Condensed Consolidated Financial Statements and accompanying footnotes (collectively the “Financial Statements”) reflect all adjustments, in the opinion of management, necessary for fair presentation of the financial condition and results of operations for the periods presented. All such adjustments are normal and recurring in nature. The Financial Statements, including selected notes, have been prepared in accordance with applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting and do not include all information and disclosures required by accounting principles generally accepted in the United States of America (“U.S. GAAP”) for comprehensive financial statement reporting. These interim Financial Statements should be read in conjunction with the audited consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2018 (“Annual Report”). A copy of the Annual Report is available on the SEC’s website, www.sec.gov , under the Company’s ticker symbol (“FTK”) or on Flotek’s website, www.flotekind.com . The results of operations for the three and nine months ended September 30, 2019 are not necessarily indicative of the results to be expected for the year ended December 31, 2019 . During the fourth quarter of 2018, the Company classified the Consumer and Industrial Chemistry Technologies segment as held for sale based on management’s intention to sell this business. The Company’s historical financial statements have been revised to present the operating results of the Consumer and Industrial Chemistry Technologies segment as discontinued operations. The results of operations of this segment are presented as “Income (loss) from discontinued operations” in the statement of operations and the related cash flows of this segment have been reclassified to discontinued operations for all periods presented. The assets and liabilities of the Consumer and Industrial Chemistry Technologies segment have been reclassified to “Assets held for sale” and “Liabilities held for sale”, respectively, in the consolidated balance sheet for all periods presented. All significant intercompany accounts and transactions have been eliminated in consolidation. The Company does not have investments in any unconsolidated subsidiaries. Leases The Company determines if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (“ROU”) assets, current portion of lease liabilities, and operating lease liabilities in the consolidated balance sheets. Finance leases are included in property and equipment, current portion of lease liabilities , and finance lease liabilities in the consolidated balance sheets. ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. As the leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. The Company uses the implicit rate when readily determinable. The lease term is modified to reflect options to extend or terminate the lease when it is reasonably certain the Company will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term. The Company has some lease agreements that contain both lease and non-lease components. The Company has elected to account for such leases as having a single lease component. Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts of assets and liabilities, disclosure of contingent assets and liabilities, and reported amounts of revenue and expenses. Actual results could differ from these estimates. Reclassifications Certain prior period amounts have been reclassified to conform to the current period presentation. The reclassifications did not impact net loss . |
Recent Accounting Pronouncement
Recent Accounting Pronouncements | 9 Months Ended |
Sep. 30, 2019 | |
New Accounting Pronouncements and Changes in Accounting Principles [Abstract] | |
Recent accounting pronouncements | Recent Accounting Pronouncements Application of New Accounting Standards Effective January 1, 2019, the Company adopted the accounting guidance in Accounting Standards Update (“ASU”) No. 2016-02, “ Leases .” This standard (ASC 842) requires the recognition of ROU assets and lease liabilities by lessees for those leases classified as operating leases under previous U.S. GAAP (ASC 840). The Company adopted ASC 842 using the optional transition method. Consequently, the Company’s reporting for the comparative periods presented prior to 2019 in the financial statements will continue to be in accordance with ASC 840. Upon adoption, the Company recorded operating lease ROU assets and corresponding operating lease liabilities, net of deferred rent, of approximately $18.4 million , representing the present value of future lease payments under operating leases with terms of greater than twelve months. The adoption of this standard did not have a material impact on the consolidated statements of operations or cash flows. Refer to Note 4 — “Leases” for further information surrounding adoption of this new standard. Effective January 1, 2019, the Company adopted ASU No. 2018-02, “ Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income .” This standard allows a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the 2017 Tax Cuts and Jobs Act. Implementation of this standard did not have a material effect on the consolidated financial statements and related disclosures. Effective January 1, 2019, the Company adopted ASU No. 2018-07, “ Improvements to Nonemployee Share-Based Payment Accounting .” This standard expands the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from non-employees. Implementation of this standard did not have a material effect on the consolidated financial statements and related disclosures. New Accounting Requirements and Disclosures In June 2016, the FASB issued ASU No. 2016-13, “ Measurement of Credit Losses on Financial Instruments .” This standard replaces the incurred loss impairment methodology in current U.S. GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. The pronouncement is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, with early adoption for the fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The Company is currently evaluating the impact the pronouncement will have on the consolidated financial statements and related disclosures. In August 2018, the FASB issued ASU No. 2018-13, “ Disclosure Framework — Changes to the Disclosure Requirements for Fair Value Measurement .” This standard removes, modifies, and adds additional requirements for disclosures related to fair value measurement in ASC 820. The pronouncement is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, with early adoption permitted in any interim period. The Company is currently evaluating the impact the pronouncement will have on the consolidated financial statements and related disclosures. |
Discontinued Operations
Discontinued Operations | 9 Months Ended |
Sep. 30, 2019 | |
Discontinued Operations and Disposal Groups [Abstract] | |
Discontinued Operations | Discontinued Operations During the fourth quarter of 2018, the Company initiated and began executing a strategic plan to sell its Consumer and Industrial Chemistry Technologies (“CICT”) segment. An investment banking advisory services firm was engaged and actively marketed this segment. The Company met all of the criteria to classify the CICT segment’s assets and liabilities as held for sale in the fourth quarter 2018. The Company has classified the assets, liabilities, and results of operations for this segment as “Discontinued Operations” for all periods presented. Disposal of the CICT reporting segment represented a strategic shift that will have a major effect on the Company’s operations and financial results. On January 10, 2019 , the Company entered into a Share Purchase Agreement with Archer-Daniels-Midland Company (“ADM”) for the sale of all of the shares representing membership interests in its wholly owned subsidiary, Florida Chemical Company, LLC, which represented the CICT segment. Effective February 28, 2019 , the Company completed the sale of the CICT segment to ADM for $175.0 million in cash consideration, with $4.4 million temporarily held in escrow by ADM for post-closing working capital adjustments for up to 90 days and $13.1 million temporarily held in escrow to satisfy potential indemnification claims by ADM with anticipated releases at 6 months , 12 months , and 15 months . As of September 30, 2019, the escrow balance including interest was $12.5 million reflected in other current assets. Pursuant to the dispute resolution procedures set forth in the Share Purchase Agreement, the Company and ADM are in the process of engaging a neutral third party arbitrator to help reach agreement on the final post-closing working capital adjustment. Concurrent with the closing of the sale of the CICT segment, the Company retained $11.1 million of historical inventory previously held by the CICT segment. In addition, the Company executed a long-term supply agreement for terpene. The term of the agreement runs through September 2023, with an option to extend for an additional year. The remaining minimum commitment of the agreement at September 30, 2019 is $72 million . The following summarized financial information has been segregated from continuing operations and reported as Discontinued Operations for the three and nine months ended September 30, 2019 and 2018 (in thousands): Three months ended September 30, Nine months ended September 30, 2019 2018 2019 2018 Consumer and Industrial Chemistry Technologies Revenue $ — $ 17,280 $ 11,031 $ 56,267 Operating expenses — (15,562 ) (11,572 ) (49,797 ) Depreciation and amortization — (699 ) — (2,049 ) Research and development — (161 ) (69 ) (483 ) (Loss) income from operations — 858 (610 ) 3,938 Other income — 59 35 251 Gain on sale of business 148 — 67,842 — Income before income taxes 148 917 67,267 4,189 Income tax expense (31 ) (6 ) (20,386 ) (13 ) Net income from discontinued operations $ 117 $ 911 $ 46,881 $ 4,176 The assets and liabilities held for sale on the Consolidated Balance Sheets as of September 30, 2019 and December 31, 2018 , are as follows (in thousands): Consumer and Industrial Chemistry Technologies September 30, 2019 December 31, 2018 Assets: Accounts receivable, net $ — $ 10,547 Inventories, net — 52,069 Other current assets — 446 Property and equipment, net — 15,899 Goodwill — 19,480 Other intangible assets, net — 20,029 Assets held for sale — 118,470 Valuation allowance — — Assets held for sale, net $ — $ 118,470 Liabilities: Accounts payable $ — $ 8,883 Accrued liabilities — 291 Liabilities held for sale $ — $ 9,174 |
Leases
Leases | 9 Months Ended |
Sep. 30, 2019 | |
Leases [Abstract] | |
Leases | Leases Effective January 1, 2019, the Company adopted ASC 842 using the prospective method applied to those leases which were not completed as of December 31, 2018. The Company has leases for corporate offices, research and development facilities, warehouses, sales offices and equipment. The leases have remaining lease terms of 1 year to 19 years , some of which include options to extend the leases for up to 10 years . Upon adoption, the Company recorded operating lease ROU assets and corresponding operating lease liabilities, net of deferred rent, of approximately $18.4 million , representing the present value of future lease payments under operating leases with terms of greater than twelve months. Leases with an initial expected term of 12 months or less are not recorded on the balance sheet. The Company recognizes lease expense for these leases on a straight-line basis over the expected lease term. The components of lease expense and supplemental cash flow information are as follows (in thousands): Three months ended September 30, 2019 Nine months ended September 30, 2019 Operating lease expense $ 652 $ 1,958 Finance lease expense: Amortization of right-of-use assets 357 577 Interest on lease liabilities 3 6 Total finance lease expense 360 583 Short-term lease expense 22 97 Total lease expense $ 1,034 $ 2,638 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 584 $ 1,749 Operating cash flows from finance leases 3 6 Financing cash flows from finance leases 6 51 Maturities of lease liabilities are as follows (in thousands): Year ending December 31, Operating Leases Finance Leases 2019 (excluding the three months ended September 30, 2019) $ 586 $ 17 2020 2,335 70 2021 2,293 70 2022 2,257 46 2023 2,166 38 Thereafter 25,695 22 Total lease payments $ 35,332 $ 263 Less: Interest (16,678 ) (43 ) Present value of lease liabilities $ 18,654 $ 220 Supplemental balance sheet information related to leases is as follows (in thousands): September 30, 2019 Operating Leases Operating lease right-of-use assets $ 17,625 Current portion of lease liabilities $ 709 Long-term operating lease liabilities 17,945 Total operating lease liabilities $ 18,654 Finance Leases Property and equipment $ 293 Accumulated depreciation (19 ) Property and equipment, net $ 274 Current portion of lease liabilities $ 48 Long-term finance lease liabilities 172 Total finance lease liabilities $ 220 Weighted Average Remaining Lease Term Operating leases 15.7 years Finance leases 4.8 years Weighted Average Discount Rate Operating leases 8.9 % Finance leases 8.5 % |
Leases | Leases Effective January 1, 2019, the Company adopted ASC 842 using the prospective method applied to those leases which were not completed as of December 31, 2018. The Company has leases for corporate offices, research and development facilities, warehouses, sales offices and equipment. The leases have remaining lease terms of 1 year to 19 years , some of which include options to extend the leases for up to 10 years . Upon adoption, the Company recorded operating lease ROU assets and corresponding operating lease liabilities, net of deferred rent, of approximately $18.4 million , representing the present value of future lease payments under operating leases with terms of greater than twelve months. Leases with an initial expected term of 12 months or less are not recorded on the balance sheet. The Company recognizes lease expense for these leases on a straight-line basis over the expected lease term. The components of lease expense and supplemental cash flow information are as follows (in thousands): Three months ended September 30, 2019 Nine months ended September 30, 2019 Operating lease expense $ 652 $ 1,958 Finance lease expense: Amortization of right-of-use assets 357 577 Interest on lease liabilities 3 6 Total finance lease expense 360 583 Short-term lease expense 22 97 Total lease expense $ 1,034 $ 2,638 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 584 $ 1,749 Operating cash flows from finance leases 3 6 Financing cash flows from finance leases 6 51 Maturities of lease liabilities are as follows (in thousands): Year ending December 31, Operating Leases Finance Leases 2019 (excluding the three months ended September 30, 2019) $ 586 $ 17 2020 2,335 70 2021 2,293 70 2022 2,257 46 2023 2,166 38 Thereafter 25,695 22 Total lease payments $ 35,332 $ 263 Less: Interest (16,678 ) (43 ) Present value of lease liabilities $ 18,654 $ 220 Supplemental balance sheet information related to leases is as follows (in thousands): September 30, 2019 Operating Leases Operating lease right-of-use assets $ 17,625 Current portion of lease liabilities $ 709 Long-term operating lease liabilities 17,945 Total operating lease liabilities $ 18,654 Finance Leases Property and equipment $ 293 Accumulated depreciation (19 ) Property and equipment, net $ 274 Current portion of lease liabilities $ 48 Long-term finance lease liabilities 172 Total finance lease liabilities $ 220 Weighted Average Remaining Lease Term Operating leases 15.7 years Finance leases 4.8 years Weighted Average Discount Rate Operating leases 8.9 % Finance leases 8.5 % |
Revenue from Contracts with Cus
Revenue from Contracts with Customers | 9 Months Ended |
Sep. 30, 2019 | |
Revenue from Contract with Customer [Abstract] | |
Revenue from Contracts with Customers | Revenue from Contracts with Customers Revenues are recognized when control of the promised goods or services is transferred to the customer, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. In recognizing revenue for products and services, the Company determines the transaction price of purchase orders or contracts with customers, which may consist of fixed and variable consideration. Determining the transaction price may require significant judgment by management, which includes identifying performance obligations, estimating variable consideration to include in the transaction price, and determining whether promised goods or services are distinct within the context of the contract. Variable consideration typically consists of product returns and is estimated based on the amount of consideration the Company expects to receive. Revenue accruals are recorded on an ongoing basis to reflect updated variable consideration information. For certain contracts, the Company recognizes revenue under the percentage-of-completion method of accounting, measured by the percentage of “costs incurred to date” to the “total estimated costs of completion.” This percentage is applied to the “total estimated revenue at completion” to calculate proportionate revenue earned to date. For the three and nine months ended September 30, 2019 and 2018 , the percentage-of-completion revenue accounted for less than 0.1% of total revenue during the respective time periods. This resulted in immaterial unfulfilled performance obligations and immaterial contract assets and/or liabilities, for which the Company did not record adjustments to opening retained earnings as of December 31, 2016 or for any periods previously presented. The vast majority of the Company’s products are sold at a point in time and service contracts are short-term in nature. Sales are billed on a monthly basis with payment terms customarily 30-45 days for domestic and 60 day for international from invoice receipt. In addition, sales taxes are excluded from revenues. Disaggregation of Revenue The Company has disaggregated revenues by product sales (point-in-time revenue recognition) and service revenue (over-time revenue recognition), where product sales accounted for over 95% of total revenue for the three and nine months ended September 30, 2019 and 2018 . The Company differentiates revenue and operating expenses (excluding depreciation and amortization) based on whether the source of revenue is attributable to products or services. Revenue and operating expenses (excluding depreciation and amortization) disaggregated by revenue source are as follows (in thousands): Three months ended September 30, Nine months ended September 30, 2019 2018 2019 2018 Revenue: Products $ 21,031 $ 52,510 $ 96,733 $ 130,652 Services 848 1,199 3,094 3,672 $ 21,879 $ 53,709 $ 99,827 $ 134,324 Operating expenses (excluding depreciation and amortization): Products $ 23,637 $ 44,048 $ 105,440 $ 114,365 Services 52 1,599 1,153 3,483 $ 23,689 $ 45,647 $ 106,593 $ 117,848 Arrangements with Multiple Performance Obligations The Company’s contracts with customers may include multiple performance obligations. For such arrangements, the total transaction price is allocated to each performance obligation in an amount based on the estimated relative standalone selling prices of the promised goods or services underlying each performance obligation. Standalone selling prices are generally determined based on the prices charged to customers (“observable standalone price”) or an expected cost plus a margin approach. For combined products and services within a contract, the Company accounts for individual products and services separately if they are distinct (i.e. if a product or service is separately identifiable from other items in the contract and if a customer can benefit from it on its own or with other resources that are readily available to the customer). The consideration is allocated between separate products and services within a contract based on the prices at the observable standalone price. For items that are not sold separately, the expected cost plus a margin approach is used to estimate the standalone selling price of each performance obligation. Contract Balances Under revenue contracts for both products and services, customers are invoiced once the performance obligations have been satisfied, at which point payment is unconditional. Accordingly, no revenue contracts give rise to contract assets or liabilities under ASC 606. |
Supplemental Cash Flow Informat
Supplemental Cash Flow Information | 9 Months Ended |
Sep. 30, 2019 | |
Supplemental Cash Flow Elements [Abstract] | |
Supplemental cash flow information | Supplemental Cash Flow Information Supplemental cash flow information is as follows (in thousands): Nine months ended September 30, 2019 2018 Supplemental cash payment information: Interest paid $ 595 $ 1,645 Income taxes paid, net of refunds 887 16 |
Inventories
Inventories | 9 Months Ended |
Sep. 30, 2019 | |
Inventory Disclosure [Abstract] | |
Inventories | Inventories Inventories are as follows (in thousands): September 30, 2019 December 31, 2018 Raw materials $ 7,339 $ 10,608 Finished goods 17,809 18,798 Inventories 25,148 29,406 Less reserve for excess and obsolete inventory (815 ) (2,117 ) Inventories, net $ 24,333 $ 27,289 |
Property and Equipment
Property and Equipment | 9 Months Ended |
Sep. 30, 2019 | |
Property, Plant and Equipment [Abstract] | |
Property and equipment | Property and Equipment Property and equipment are as follows (in thousands): September 30, 2019 December 31, 2018 Land $ 4,372 $ 4,372 Buildings and leasehold improvements 37,729 37,719 Machinery and equipment 26,871 26,995 Fixed assets in progress 1,462 581 Furniture and fixtures 1,670 1,573 Transportation equipment 1,448 1,852 Computer equipment and software 5,212 9,370 Property and equipment 78,764 82,462 Less accumulated depreciation (37,584 ) (36,977 ) Property and equipment, net $ 41,180 $ 45,485 Depreciation expense totaled $1.6 million and $1.9 million for the three months ended September 30, 2019 and 2018 , respectively, and $5.0 million and $5.9 million for the nine months ended September 30, 2019 and 2018 , respectively. During the three and nine months ended September 30, 2019 and 2018 , no impairments were recognized related to property and equipment. |
Goodwill
Goodwill | 9 Months Ended |
Sep. 30, 2019 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Goodwill | Goodwill During the second quarter of 2018, the Company recognized a goodwill impairment charge of $37.2 million in the Energy Chemistry Technologies (“ECT”) reporting unit, which resulted from sustained under-performance and lower expectations related to the reporting unit. As a result of these factors, a qualitative analysis, and additional risks associated with the business, the Company concluded that sufficient indicators existed to require an interim quantitative assessment of goodwill for that reporting unit as of September 30, 2018 . The fair value of the reporting unit was estimated based on an analysis of the present value of future discounted cash flows. The significant estimates used in the discounted cash flows model included the Company’s weighted average cost of capital, projected cash flows and the long-term rate of growth. The assumptions were based on the actual historical performance of the reporting unit and took into account a recent weakening of operating results in an improving market environment. The excess of the reporting unit’s carrying value over the estimated fair value was recorded as the goodwill impairment charge in the second quarter 2018 and represented all of the ECT reporting unit’s goodwill. The Company has no reporting units which had a goodwill balance at December 31, 2018 , and there were no acquisitions during the three and nine months ended September 30, 2019 . |
Other Intangible Assets
Other Intangible Assets | 9 Months Ended |
Sep. 30, 2019 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Other intangible assets | Other Intangible Assets Other intangible assets are as follows (in thousands): September 30, 2019 December 31, 2018 Cost Accumulated Amortization Cost Accumulated Amortization Finite-lived intangible assets: Patents and technology $ 16,711 $ 6,427 $ 17,399 $ 6,689 Customer lists 15,367 5,824 15,367 5,259 Trademarks and brand names 1,349 1,150 1,385 1,149 Intangible assets in progress 792 — 1,614 — Total finite-lived intangible assets acquired 34,219 13,401 35,765 13,097 Deferred financing costs — — 1,895 496 Total amortizable intangible assets 34,219 $ 13,401 37,660 $ 13,593 Indefinite-lived intangible assets: Trademarks and brand names 2,760 2,760 Total other intangible assets $ 36,979 $ 40,420 Carrying value: Other intangible assets, net $ 23,578 $ 26,827 Finite-lived intangible assets acquired are amortized on a straight-line basis over two to 20 years . Amortization of finite-lived intangible assets acquired totaled $0.5 million and $0.3 million for the three months ended September 30, 2019 and 2018 , respectively, and $1.5 million and $1.0 million for the nine months ended September 30, 2019 and 2018 . Amortization of deferred financing costs totaled zero and $0.1 million for the three months ended September 30, 2019 and 2018 , respectively, and $1.4 million and 0.3 million for the nine months ended September 30, 2019 and 2018 . |
Long-Term Debt and Credit Facil
Long-Term Debt and Credit Facility | 9 Months Ended |
Sep. 30, 2019 | |
Debt Disclosure [Abstract] | |
Long-term debt and credit facility | Long-Term Debt and Credit Facility Long-term debt is as follows (in thousands): September 30, 2019 December 31, 2018 Long-term debt, classified as current: Borrowings under revolving credit facility $ — $ 49,731 Borrowing under the revolving credit agreement at December 31, 2018 was classified as current debt. Credit Facility On May 10, 2013 , the Company and certain of its subsidiaries entered into an Amended and Restated Revolving Credit, Term Loan and Security Agreement (as amended, the “Credit Facility”) with PNC Bank, National Association (“PNC Bank”). The Company could borrow under the Credit Facility for working capital, permitted acquisitions, capital expenditures and other corporate purposes. The Credit Facility was to continue in effect until May 10, 2022 . Under terms of the Credit Facility, the Company had total borrowing availability of $75 million under a revolving credit facility, including a sublimit of $10 million that could be used for letters of credit. On March 1, 2019 , the Company repaid the outstanding balance, interest, and fees related to the revolving credit facility, and simultaneously terminated the Credit Facility. Simultaneously with the termination of the Credit Facility, the Company expensed the remaining amount of deferred financing costs totaling $1.4 million . |
Earnings (Loss) Per Share
Earnings (Loss) Per Share | 9 Months Ended |
Sep. 30, 2019 | |
Earnings Per Share [Abstract] | |
Earnings (loss) per share | Earnings (Loss) Per Share Basic earnings (loss) per common share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding for the period. Diluted earnings (loss) per common share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding combined with dilutive common share equivalents outstanding, if the effect is dilutive. Potentially dilutive securities were excluded from the calculation of diluted loss per share for the three and nine months ended September 30, 2019 and 2018 , since including them would have an anti-dilutive effect on loss per share due to the net loss incurred during the periods. Securities convertible into shares of common stock that were not considered in the diluted loss per share calculations were 0.5 million restricted stock units for the three and nine months ended September 30, 2019 , and 0.9 million restricted stock units for the three and nine months ended September 30, 2018 . |
Fair Value Measurements
Fair Value Measurements | 9 Months Ended |
Sep. 30, 2019 | |
Fair Value Disclosures [Abstract] | |
Fair value measurements | Fair Value Measurements Fair value is defined as the amount that would be received for selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company categorizes financial assets and liabilities into the three levels of the fair value hierarchy. The hierarchy prioritizes the inputs to valuation techniques used to measure fair value and bases categorization within the hierarchy on the lowest level of input that is available and significant to the fair value measurement. • Level 1 — Quoted prices in active markets for identical assets or liabilities; • Level 2 — Observable inputs other than Level 1, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and • Level 3 — Significant unobservable inputs that are supported by little or no market activity or that are based on the reporting entity’s assumptions about the inputs. Fair Value of Other Financial Instruments The carrying amounts of certain financial instruments, including cash and cash equivalents, accounts receivable, accounts payable, and accrued expenses, approximate fair value due to the short-term nature of these accounts. The Company had total cash of $107.0 million , which consisted of cash equivalents of $57.7 million in a government money market account and cash deposits of $45.5 million in an interest bearing demand deposit account and $3.8 million in operating cash accounts, at September 30, 2019 , and $3.0 million , which consisted of no cash equivalents and cash deposits of $3.0 million in operating cash accounts, at December 31, 2018 . The carrying amount and estimated fair value of the Company’s long-term debt are as follows (in thousands): September 30, 2019 December 31, 2018 Carrying Amount Fair Value Carrying Amount Fair Value Borrowings under Credit Facility — — 49,731 49,731 The carrying amount of borrowings under the Credit Facility approximates its fair value because the interest rates are variable. Assets Measured at Fair Value on a Nonrecurring Basis The Company’s non-financial assets, including property and equipment, goodwill, and other intangible assets are measured at fair value on a non-recurring basis and are subject to fair value adjustment in certain circumstances. During the three months ended June 30, 2018, the Company recorded an impairment of $37.2 million for goodwill in the Energy Chemistry Technologies reporting unit. No impairments of any of these assets were recognized during the three and nine months ended September 30, 2019 . |
Income Taxes
Income Taxes | 9 Months Ended |
Sep. 30, 2019 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income Taxes A reconciliation of the U.S. federal statutory tax rate to the Company’s effective income tax rate is as follows: Three months ended September 30, Nine months ended September 30, 2019 2018 2019 2018 U.S. federal statutory tax rate 21.0 % 21.0 % 21.0 % 21.0 % State income taxes, net of federal benefit 1.7 1.5 1.2 (0.2 ) Non-U.S. income taxed at different rates 0.2 3.9 0.8 0.6 Reduction in tax benefit related to stock-based awards (0.6 ) (4.9 ) (1.4 ) (1.7 ) Non-deductible expenses (0.7 ) (8.6 ) (0.4 ) (9.2 ) Research and development credit (expense) 0.2 (3.5 ) 0.5 0.3 Increase in valuation allowance (18.8 ) (3.4 ) (18.2 ) (33.6 ) Other (1.4 ) — (0.7 ) — Effective income tax rate 1.6 % 6.0 % 2.8 % (22.8 )% Fluctuations in effective tax rates have historically been impacted by permanent tax differences with no associated income tax impact, changes in the valuation allowance, changes in state apportionment factors, including the effect on state deferred tax assets and liabilities, and non-U.S. income taxed at different rates. Net deferred tax assets arise due to the recognition of income and expense items for tax purposes, which differ from those used for financial statement purposes. ASC 740, Income Taxes, provides for the recognition of deferred tax assets if realization of such assets is more likely than not. In assessing the need for a valuation allowance in the second quarter of 2018, the Company considered all available objective and verifiable evidence, both positive and negative, including historical levels of pre-tax income (loss) both on a consolidated basis and tax reporting entity basis, legislative developments, and expectations and risks associated with estimates of future pre-tax income. As a result of this analysis, the Company determined that it was more likely than not that it would not realize the benefits of certain deferred tax assets and, therefore, recorded a $15.5 million valuation allowance against the carrying value of net deferred tax assets, except for deferred tax liabilities related to non-amortizable intangible assets and certain state jurisdictions. As all available evidence should be taken into consideration when assessing the need for a valuation allowance, the sale of the CICT segment provided a source of income to support the release of $11.5 million of the valuation allowance which resulted in a deferred tax asset of $18.7 million . As such, the Company reversed this portion of the valuation allowance during the fourth quarter of 2018. The increase in the valuation allowance during the nine months ended September 30, 2019, reflects management’s evaluation of deferred tax assets more-likely-than-not to be used after giving consideration to the gain from the sale of the CICT segment and anticipated results of operations. In January 2017, the Internal Revenue Service notified the Company that it would examine the Company’s federal tax returns for the year ended December 31, 2014. The examination included (1) the corporate returns and (2) employment tax matters. The IRS fieldwork has been completed in relation to the corporate returns with no adverse findings. Further discussion of the employment tax matter can be found in Note 18 — “Related Party Transaction.” |
Common Stock
Common Stock | 9 Months Ended |
Sep. 30, 2019 | |
Equity [Abstract] | |
Common Stock | Common Stock The Company’s Certificate of Incorporation, as amended on November 9, 2009, authorizes the Company to issue up to 80 million shares of common stock, par value $0.0001 per share, and 100,000 shares of one or more series of preferred stock, par value $0.0001 per share. A reconciliation of changes in common shares issued during the nine months ended September 30, 2019 is as follows: Shares issued at December 31, 2018 62,162,875 Issued as restricted stock award grants 875,522 Shares issued at September 30, 2019 63,038,397 Stock Repurchase Program In June 2015, the Company’s Board of Directors authorized the repurchase of up to $50 million of the Company’s common stock. Repurchases may be made in the open market or through privately negotiated transactions. Through December 31, 2018 , the Company had repurchased $0.3 million of its common stock under this authorization. During the three and nine months ended September 30, 2019 and 2018 , the Company did no t repurchase any shares of its outstanding common stock under this authorization. At September 30, 2019 , the Company has $49.7 million remaining under its share repurchase program. |
Business Segment, Geographic an
Business Segment, Geographic and Major Customer Information | 9 Months Ended |
Sep. 30, 2019 | |
Segment Reporting [Abstract] | |
Business Segment, Geographic and Major Customer Information | Business Segment, Geographic and Major Customer Information Segment Information Operating segments are defined as components of an enterprise for which separate financial information is available that is regularly evaluated by chief operating decision-makers in deciding how to allocate resources and assess performance. The operations of the Company are categorized into one reportable segment: Energy Chemistry Technologies. Energy Chemistry Technologies designs, develops, manufactures, packages, distributes, delivers, and markets reservoir-centric fluid systems, including specialty and conventional chemistries, for use in O&G well drilling, cementing, completion, remediation, and stimulation activities designed to maximize recovery in both new and mature fields. Activities in this segment also include construction and management of automated material handling facilities as well as management of loading facilities and blending operations for oilfield services companies. The Company evaluates performance based upon a variety of criteria. The primary financial measure is segment operating income. Various functions, including certain sales and marketing activities and general and administrative activities, are provided centrally by the corporate office. Costs associated with corporate office functions, other corporate income and expense items, and income taxes are not allocated to the reportable segment. Summarized financial information of the reportable segments is as follows (in thousands): For the three months ended September 30, Energy Chemistry Technologies Corporate and Other Total 2019 Net revenue from external customers $ 21,879 $ — $ 21,879 Loss from operations (5,984 ) (5,869 ) (11,853 ) Depreciation and amortization 1,870 188 2,058 Capital expenditures 1,102 — 1,102 2018 Net revenue from external customers $ 53,709 $ — $ 53,709 Income (loss) from operations 3,921 (8,001 ) (4,080 ) Depreciation and amortization 1,734 525 2,259 Capital expenditures 302 861 1,163 For the nine months ended September 30, Energy Chemistry Technologies Corporate and Other Total 2019 Net revenue from external customers $ 99,827 $ — $ 99,827 Loss from operations (18,968 ) (21,008 ) (39,976 ) Depreciation and amortization 5,588 849 6,437 Capital expenditures 1,869 — 1,869 2018 Net revenue from external customers $ 134,324 $ — $ 134,324 Loss from operations (34,176 ) (26,270 ) (60,446 ) Depreciation and amortization 5,300 1,635 6,935 Capital expenditures 2,480 1,314 3,794 Assets of the Company by reportable segments are as follows (in thousands): September 30, 2019 December 31, 2018 Energy Chemistry Technologies $ 123,309 $ 139,205 Corporate and Other 126,048 28,208 Total segments 249,357 167,413 Held for sale — 118,470 Total assets $ 249,357 $ 285,883 Geographic Information Revenue by country is based on the location where services are provided and products are used. No individual country other than the United States (“U.S.”) accounted for more than 10% of revenue, except as noted below. Revenue by geographic location is as follows (in thousands): Three months ended September 30, Nine months ended September 30, 2019 2018 2019 2018 U.S. $ 19,663 $ 35,685 $ 89,653 $ 108,571 Other countries 2,216 18,024 10,174 25,753 Total $ 21,879 $ 53,709 $ 99,827 $ 134,324 Long-lived assets held in countries other than the U.S. are not considered material to the consolidated financial statements. Major Customers Revenue from major customers, as a percentage of consolidated revenue, is as follows: Three months ended September 30, Nine months ended September 30, 2019 2018 2019 2018 Customer A 35.9 % * 16.7 % * Customer B * 12.2 % 12.3 % 10.4 % Customer C 6.6 % 25.6 % * 13.6 % * This customer did not account for more than 10% of revenue. |
Commitments and Contingencies
Commitments and Contingencies | 9 Months Ended |
Sep. 30, 2019 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and contingencies | Commitments and Contingencies Class Action Litigation On March 30, 2017, the U.S. District Court for the Southern District of Texas granted the Company’s motion to dismiss the four consolidated putative securities class action lawsuits that were filed in November 2015, against the Company and certain of its officers. The lawsuits were previously consolidated into a single case, and a consolidated amended complaint had been filed. The consolidated amended complaint asserted that the Company made false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. The complaint sought an award of damages in an unspecified amount on behalf of a putative class consisting of persons who purchased the Company’s common stock between October 23, 2014 and November 9, 2015, inclusive. The lead plaintiff appealed the District Court’s decision granting the motion to dismiss. On February 7, 2019, a three-judge panel of the United States Court of Appeals for the Fifth Circuit issued a unanimous opinion affirming the District Court’s judgment of dismissal in its entirety. Other Litigation The Company is subject to routine litigation and other claims that arise in the normal course of business. Management is not aware of any pending or threatened lawsuits or proceedings that are expected to have a material effect on the Company’s financial position, results of operations or liquidity. Concentrations and Credit Risk The majority of the Company’s revenue is derived from O&G industry. Customers include major oilfield services companies, major integrated oil and natural gas companies, independent oil and natural gas companies, pressure pumping service companies, and state-owned national oil companies. This concentration of customers in one industry increases credit and business risks. The Company is subject to concentrations of credit risk within trade accounts receivable, as the Company does not generally require collateral as support for trade receivables. In addition, the majority of the Company’s cash is invested in accounts in two major financial institutions and balances often exceed insurable amounts. |
Related Party Transaction
Related Party Transaction | 9 Months Ended |
Sep. 30, 2019 | |
Related Party Transactions [Abstract] | |
Related party transaction | Related Party Transaction In January 2017, the Internal Revenue Service (“IRS”) notified the Company that it was examining the Company’s federal tax returns for the year ended December 31, 2014. As a result of this examination, the IRS informed the Company on May 1, 2019 that certain employment taxes related to the CEO’s compensation were not properly withheld in 2014 and proposed an adjustment. The CEO’s affiliated companies through which he provided his services have agreed to indemnify the Company for any such taxes, and the CEO has executed a personal guaranty in favor of the Company, supporting this indemnification. At June 30, 2019, the Company recorded a liability of $2.4 million related to the estimated employment tax under-withholding for the years 2014 through 2018. By September 30, 2019, the liability totaled $1.8 million , after the Company paid $0.6 million to the IRS for these taxes and made an additional accrual covering the estimated under-withholding tax liability through 2019. In addition, at September 30, 2019 the Company recorded a receivable from the CEO’s affiliated companies totaling $2.4 million |
Organization and Significant _2
Organization and Significant Accounting Policies (Policies) | 9 Months Ended |
Sep. 30, 2019 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Basis of Presentation | Basis of Presentation The accompanying Unaudited Condensed Consolidated Financial Statements and accompanying footnotes (collectively the “Financial Statements”) reflect all adjustments, in the opinion of management, necessary for fair presentation of the financial condition and results of operations for the periods presented. All such adjustments are normal and recurring in nature. The Financial Statements, including selected notes, have been prepared in accordance with applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting and do not include all information and disclosures required by accounting principles generally accepted in the United States of America (“U.S. GAAP”) for comprehensive financial statement reporting. These interim Financial Statements should be read in conjunction with the audited consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2018 (“Annual Report”). A copy of the Annual Report is available on the SEC’s website, www.sec.gov , under the Company’s ticker symbol (“FTK”) or on Flotek’s website, www.flotekind.com |
Leases | Leases The Company determines if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (“ROU”) assets, current portion of lease liabilities, and operating lease liabilities in the consolidated balance sheets. Finance leases are included in property and equipment, current portion of lease liabilities , and finance lease liabilities in the consolidated balance sheets. ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. As the leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. The Company uses the implicit rate when readily determinable. The lease term is modified to reflect options to extend or terminate the lease when it is reasonably certain the Company will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term. The Company has some lease agreements that contain both lease and non-lease components. The Company has elected to account for such leases as having a single lease component. |
Use of Estimates | Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts of assets and liabilities, disclosure of contingent assets and liabilities, and reported amounts of revenue and expenses. Actual results could differ from these estimates. |
Reclassifications | Reclassifications Certain prior period amounts have been reclassified to conform to the current period presentation. The reclassifications did not impact net loss . |
Recent accounting pronouncements | Recent Accounting Pronouncements Application of New Accounting Standards Effective January 1, 2019, the Company adopted the accounting guidance in Accounting Standards Update (“ASU”) No. 2016-02, “ Leases .” This standard (ASC 842) requires the recognition of ROU assets and lease liabilities by lessees for those leases classified as operating leases under previous U.S. GAAP (ASC 840). The Company adopted ASC 842 using the optional transition method. Consequently, the Company’s reporting for the comparative periods presented prior to 2019 in the financial statements will continue to be in accordance with ASC 840. Upon adoption, the Company recorded operating lease ROU assets and corresponding operating lease liabilities, net of deferred rent, of approximately $18.4 million , representing the present value of future lease payments under operating leases with terms of greater than twelve months. The adoption of this standard did not have a material impact on the consolidated statements of operations or cash flows. Refer to Note 4 — “Leases” for further information surrounding adoption of this new standard. Effective January 1, 2019, the Company adopted ASU No. 2018-02, “ Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income .” This standard allows a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the 2017 Tax Cuts and Jobs Act. Implementation of this standard did not have a material effect on the consolidated financial statements and related disclosures. Effective January 1, 2019, the Company adopted ASU No. 2018-07, “ Improvements to Nonemployee Share-Based Payment Accounting .” This standard expands the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from non-employees. Implementation of this standard did not have a material effect on the consolidated financial statements and related disclosures. New Accounting Requirements and Disclosures In June 2016, the FASB issued ASU No. 2016-13, “ Measurement of Credit Losses on Financial Instruments .” This standard replaces the incurred loss impairment methodology in current U.S. GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. The pronouncement is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, with early adoption for the fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The Company is currently evaluating the impact the pronouncement will have on the consolidated financial statements and related disclosures. In August 2018, the FASB issued ASU No. 2018-13, “ Disclosure Framework — Changes to the Disclosure Requirements for Fair Value Measurement .” This standard removes, modifies, and adds additional requirements for disclosures related to fair value measurement in ASC 820. The pronouncement is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, with early adoption permitted in any interim period. The Company is currently evaluating the impact the pronouncement will have on the consolidated financial statements and related disclosures. |
Earnings (loss) per share | Earnings (Loss) Per Share Basic earnings (loss) per common share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding for the period. Diluted earnings (loss) per common share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding combined with dilutive common share equivalents outstanding, if the effect is dilutive. Potentially dilutive securities were excluded from the calculation of diluted loss per share for the three and nine months ended September 30, 2019 and 2018 |
Fair value measurements | Fair Value Measurements Fair value is defined as the amount that would be received for selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company categorizes financial assets and liabilities into the three levels of the fair value hierarchy. The hierarchy prioritizes the inputs to valuation techniques used to measure fair value and bases categorization within the hierarchy on the lowest level of input that is available and significant to the fair value measurement. • Level 1 — Quoted prices in active markets for identical assets or liabilities; • Level 2 — Observable inputs other than Level 1, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and • Level 3 — Significant unobservable inputs that are supported by little or no market activity or that are based on the reporting entity’s assumptions about the inputs. |
Segment Information | Segment Information Operating segments are defined as components of an enterprise for which separate financial information is available that is regularly evaluated by chief operating decision-makers in deciding how to allocate resources and assess performance. The operations of the Company are categorized into one reportable segment: Energy Chemistry Technologies. Energy Chemistry Technologies designs, develops, manufactures, packages, distributes, delivers, and markets reservoir-centric fluid systems, including specialty and conventional chemistries, for use in O&G well drilling, cementing, completion, remediation, and stimulation activities designed to maximize recovery in both new and mature fields. Activities in this segment also include construction and management of automated material handling facilities as well as management of loading facilities and blending operations for oilfield services companies. The Company evaluates performance based upon a variety of criteria. The primary financial measure is segment operating income. Various functions, including certain sales and marketing activities and general and administrative activities, are provided centrally by the corporate office. Costs associated with corporate office functions, other corporate income and expense items, and income taxes are not allocated to the reportable segment. |
Discontinued Operations (Tables
Discontinued Operations (Tables) | 9 Months Ended |
Sep. 30, 2019 | |
Discontinued Operations and Disposal Groups [Abstract] | |
Summary of financial information has been segregated from continuing operations | The following summarized financial information has been segregated from continuing operations and reported as Discontinued Operations for the three and nine months ended September 30, 2019 and 2018 (in thousands): Three months ended September 30, Nine months ended September 30, 2019 2018 2019 2018 Consumer and Industrial Chemistry Technologies Revenue $ — $ 17,280 $ 11,031 $ 56,267 Operating expenses — (15,562 ) (11,572 ) (49,797 ) Depreciation and amortization — (699 ) — (2,049 ) Research and development — (161 ) (69 ) (483 ) (Loss) income from operations — 858 (610 ) 3,938 Other income — 59 35 251 Gain on sale of business 148 — 67,842 — Income before income taxes 148 917 67,267 4,189 Income tax expense (31 ) (6 ) (20,386 ) (13 ) Net income from discontinued operations $ 117 $ 911 $ 46,881 $ 4,176 The assets and liabilities held for sale on the Consolidated Balance Sheets as of September 30, 2019 and December 31, 2018 , are as follows (in thousands): Consumer and Industrial Chemistry Technologies September 30, 2019 December 31, 2018 Assets: Accounts receivable, net $ — $ 10,547 Inventories, net — 52,069 Other current assets — 446 Property and equipment, net — 15,899 Goodwill — 19,480 Other intangible assets, net — 20,029 Assets held for sale — 118,470 Valuation allowance — — Assets held for sale, net $ — $ 118,470 Liabilities: Accounts payable $ — $ 8,883 Accrued liabilities — 291 Liabilities held for sale $ — $ 9,174 |
Leases (Tables)
Leases (Tables) | 9 Months Ended |
Sep. 30, 2019 | |
Leases [Abstract] | |
Schedule of components of lease expense and supplemental cash flow information | The components of lease expense and supplemental cash flow information are as follows (in thousands): Three months ended September 30, 2019 Nine months ended September 30, 2019 Operating lease expense $ 652 $ 1,958 Finance lease expense: Amortization of right-of-use assets 357 577 Interest on lease liabilities 3 6 Total finance lease expense 360 583 Short-term lease expense 22 97 Total lease expense $ 1,034 $ 2,638 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 584 $ 1,749 Operating cash flows from finance leases 3 6 Financing cash flows from finance leases 6 51 |
Schedule of maturities of lease liabilities | Maturities of lease liabilities are as follows (in thousands): Year ending December 31, Operating Leases Finance Leases 2019 (excluding the three months ended September 30, 2019) $ 586 $ 17 2020 2,335 70 2021 2,293 70 2022 2,257 46 2023 2,166 38 Thereafter 25,695 22 Total lease payments $ 35,332 $ 263 Less: Interest (16,678 ) (43 ) Present value of lease liabilities $ 18,654 $ 220 |
Schedule of maturities of lease liabilities | Maturities of lease liabilities are as follows (in thousands): Year ending December 31, Operating Leases Finance Leases 2019 (excluding the three months ended September 30, 2019) $ 586 $ 17 2020 2,335 70 2021 2,293 70 2022 2,257 46 2023 2,166 38 Thereafter 25,695 22 Total lease payments $ 35,332 $ 263 Less: Interest (16,678 ) (43 ) Present value of lease liabilities $ 18,654 $ 220 |
Schedule of supplemental balance sheet information | Supplemental balance sheet information related to leases is as follows (in thousands): September 30, 2019 Operating Leases Operating lease right-of-use assets $ 17,625 Current portion of lease liabilities $ 709 Long-term operating lease liabilities 17,945 Total operating lease liabilities $ 18,654 Finance Leases Property and equipment $ 293 Accumulated depreciation (19 ) Property and equipment, net $ 274 Current portion of lease liabilities $ 48 Long-term finance lease liabilities 172 Total finance lease liabilities $ 220 Weighted Average Remaining Lease Term Operating leases 15.7 years Finance leases 4.8 years Weighted Average Discount Rate Operating leases 8.9 % Finance leases 8.5 % |
Revenue from Contracts with C_2
Revenue from Contracts with Customers (Tables) | 9 Months Ended |
Sep. 30, 2019 | |
Revenue from Contract with Customer [Abstract] | |
Schedule of disaggregation of revenue | Revenue and operating expenses (excluding depreciation and amortization) disaggregated by revenue source are as follows (in thousands): Three months ended September 30, Nine months ended September 30, 2019 2018 2019 2018 Revenue: Products $ 21,031 $ 52,510 $ 96,733 $ 130,652 Services 848 1,199 3,094 3,672 $ 21,879 $ 53,709 $ 99,827 $ 134,324 Operating expenses (excluding depreciation and amortization): Products $ 23,637 $ 44,048 $ 105,440 $ 114,365 Services 52 1,599 1,153 3,483 $ 23,689 $ 45,647 $ 106,593 $ 117,848 |
Supplemental Cash Flow Inform_2
Supplemental Cash Flow Information (Tables) | 9 Months Ended |
Sep. 30, 2019 | |
Supplemental Cash Flow Elements [Abstract] | |
Components of supplemental cash flow information | Supplemental cash flow information is as follows (in thousands): Nine months ended September 30, 2019 2018 Supplemental cash payment information: Interest paid $ 595 $ 1,645 Income taxes paid, net of refunds 887 16 |
Inventories (Tables)
Inventories (Tables) | 9 Months Ended |
Sep. 30, 2019 | |
Inventory Disclosure [Abstract] | |
Schedule of components of inventory | Inventories are as follows (in thousands): September 30, 2019 December 31, 2018 Raw materials $ 7,339 $ 10,608 Finished goods 17,809 18,798 Inventories 25,148 29,406 Less reserve for excess and obsolete inventory (815 ) (2,117 ) Inventories, net $ 24,333 $ 27,289 |
Property and Equipment (Tables)
Property and Equipment (Tables) | 9 Months Ended |
Sep. 30, 2019 | |
Property, Plant and Equipment [Abstract] | |
Components of property and equipment | Property and equipment are as follows (in thousands): September 30, 2019 December 31, 2018 Land $ 4,372 $ 4,372 Buildings and leasehold improvements 37,729 37,719 Machinery and equipment 26,871 26,995 Fixed assets in progress 1,462 581 Furniture and fixtures 1,670 1,573 Transportation equipment 1,448 1,852 Computer equipment and software 5,212 9,370 Property and equipment 78,764 82,462 Less accumulated depreciation (37,584 ) (36,977 ) Property and equipment, net $ 41,180 $ 45,485 |
Other Intangible Assets (Tables
Other Intangible Assets (Tables) | 9 Months Ended |
Sep. 30, 2019 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Schedule of other intangible assets | Other intangible assets are as follows (in thousands): September 30, 2019 December 31, 2018 Cost Accumulated Amortization Cost Accumulated Amortization Finite-lived intangible assets: Patents and technology $ 16,711 $ 6,427 $ 17,399 $ 6,689 Customer lists 15,367 5,824 15,367 5,259 Trademarks and brand names 1,349 1,150 1,385 1,149 Intangible assets in progress 792 — 1,614 — Total finite-lived intangible assets acquired 34,219 13,401 35,765 13,097 Deferred financing costs — — 1,895 496 Total amortizable intangible assets 34,219 $ 13,401 37,660 $ 13,593 Indefinite-lived intangible assets: Trademarks and brand names 2,760 2,760 Total other intangible assets $ 36,979 $ 40,420 Carrying value: Other intangible assets, net $ 23,578 $ 26,827 |
Long-Term Debt and Credit Fac_2
Long-Term Debt and Credit Facility (Tables) | 9 Months Ended |
Sep. 30, 2019 | |
Debt Disclosure [Abstract] | |
Components of long-term debt | Long-term debt is as follows (in thousands): September 30, 2019 December 31, 2018 Long-term debt, classified as current: Borrowings under revolving credit facility $ — $ 49,731 |
Fair Value Measurements (Tables
Fair Value Measurements (Tables) | 9 Months Ended |
Sep. 30, 2019 | |
Fair Value Disclosures [Abstract] | |
Carrying value and estimated fair value of long-term debt | The carrying amount and estimated fair value of the Company’s long-term debt are as follows (in thousands): September 30, 2019 December 31, 2018 Carrying Amount Fair Value Carrying Amount Fair Value Borrowings under Credit Facility — — 49,731 49,731 |
Income Taxes (Tables)
Income Taxes (Tables) | 9 Months Ended |
Sep. 30, 2019 | |
Income Tax Disclosure [Abstract] | |
Reconciliation of effective tax rate to the U.S. federal statutory tax rate | A reconciliation of the U.S. federal statutory tax rate to the Company’s effective income tax rate is as follows: Three months ended September 30, Nine months ended September 30, 2019 2018 2019 2018 U.S. federal statutory tax rate 21.0 % 21.0 % 21.0 % 21.0 % State income taxes, net of federal benefit 1.7 1.5 1.2 (0.2 ) Non-U.S. income taxed at different rates 0.2 3.9 0.8 0.6 Reduction in tax benefit related to stock-based awards (0.6 ) (4.9 ) (1.4 ) (1.7 ) Non-deductible expenses (0.7 ) (8.6 ) (0.4 ) (9.2 ) Research and development credit (expense) 0.2 (3.5 ) 0.5 0.3 Increase in valuation allowance (18.8 ) (3.4 ) (18.2 ) (33.6 ) Other (1.4 ) — (0.7 ) — Effective income tax rate 1.6 % 6.0 % 2.8 % (22.8 )% |
Common Stock (Tables)
Common Stock (Tables) | 9 Months Ended |
Sep. 30, 2019 | |
Equity [Abstract] | |
Schedule of reconciliation of changes in common shares issued | A reconciliation of changes in common shares issued during the nine months ended September 30, 2019 is as follows: Shares issued at December 31, 2018 62,162,875 Issued as restricted stock award grants 875,522 Shares issued at September 30, 2019 63,038,397 |
Business Segment, Geographic _2
Business Segment, Geographic and Major Customer Information (Tables) | 9 Months Ended |
Sep. 30, 2019 | |
Segment Reporting [Abstract] | |
Summary of financial information regarding reportable segments | Summarized financial information of the reportable segments is as follows (in thousands): For the three months ended September 30, Energy Chemistry Technologies Corporate and Other Total 2019 Net revenue from external customers $ 21,879 $ — $ 21,879 Loss from operations (5,984 ) (5,869 ) (11,853 ) Depreciation and amortization 1,870 188 2,058 Capital expenditures 1,102 — 1,102 2018 Net revenue from external customers $ 53,709 $ — $ 53,709 Income (loss) from operations 3,921 (8,001 ) (4,080 ) Depreciation and amortization 1,734 525 2,259 Capital expenditures 302 861 1,163 For the nine months ended September 30, Energy Chemistry Technologies Corporate and Other Total 2019 Net revenue from external customers $ 99,827 $ — $ 99,827 Loss from operations (18,968 ) (21,008 ) (39,976 ) Depreciation and amortization 5,588 849 6,437 Capital expenditures 1,869 — 1,869 2018 Net revenue from external customers $ 134,324 $ — $ 134,324 Loss from operations (34,176 ) (26,270 ) (60,446 ) Depreciation and amortization 5,300 1,635 6,935 Capital expenditures 2,480 1,314 3,794 Assets of the Company by reportable segments are as follows (in thousands): September 30, 2019 December 31, 2018 Energy Chemistry Technologies $ 123,309 $ 139,205 Corporate and Other 126,048 28,208 Total segments 249,357 167,413 Held for sale — 118,470 Total assets $ 249,357 $ 285,883 |
Schedule of revenue by geographic location | Revenue by geographic location is as follows (in thousands): Three months ended September 30, Nine months ended September 30, 2019 2018 2019 2018 U.S. $ 19,663 $ 35,685 $ 89,653 $ 108,571 Other countries 2,216 18,024 10,174 25,753 Total $ 21,879 $ 53,709 $ 99,827 $ 134,324 |
Schedule of revenue by major customer | Revenue from major customers, as a percentage of consolidated revenue, is as follows: Three months ended September 30, Nine months ended September 30, 2019 2018 2019 2018 Customer A 35.9 % * 16.7 % * Customer B * 12.2 % 12.3 % 10.4 % Customer C 6.6 % 25.6 % * 13.6 % * This customer did not account for more than 10% of revenue. |
Organization and Significant _3
Organization and Significant Accounting Policies (Details) | Sep. 30, 2019country |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Number of countries Flotek actively markets products and services (over) | 15 |
Recent Accounting Pronounceme_2
Recent Accounting Pronouncements (Details) - USD ($) $ in Thousands | Sep. 30, 2019 | Jan. 01, 2019 |
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||
Operating lease right-of-use assets | $ 17,625 | |
Long-term operating lease liabilities | $ 17,945 | |
Accounting Standards Update 2016-02 | ||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||
Operating lease right-of-use assets | $ 18,400 | |
Long-term operating lease liabilities | $ 18,400 |
Discontinued Operations - Addit
Discontinued Operations - Additional Disclosures (Details) - USD ($) $ in Millions | Feb. 28, 2019 | Sep. 30, 2019 |
Consumer and Industrial Chemistry Technologies | Discontinued operations, disposed of by sale | ||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||
Cash consideration | $ 175 | |
Inventory retained | $ 11.1 | |
Remaining minimum amount committed | 72 | |
Working Adjustment Period 1 | Consumer and Industrial Chemistry Technologies | Discontinued operations, disposed of by sale | ||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||
Contingent liabilities remaining period | 90 days | |
Contingent liabilities remaining | $ 4.4 | |
Working Adjustment Period 2-4 | Consumer and Industrial Chemistry Technologies | Discontinued operations, disposed of by sale | ||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||
Contingent liabilities remaining | $ 13.1 | |
Working Adjustment Period 2 | Consumer and Industrial Chemistry Technologies | Discontinued operations, disposed of by sale | ||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||
Contingent liabilities remaining period | 6 months | |
Working Adjustment Period 3 | Consumer and Industrial Chemistry Technologies | Discontinued operations, disposed of by sale | ||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||
Contingent liabilities remaining period | 12 months | |
Working Adjustment Period 4 | Consumer and Industrial Chemistry Technologies | Discontinued operations, disposed of by sale | ||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||
Contingent liabilities remaining period | 15 months | |
Other current assets | ||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||
Escrow | $ 12.5 |
Discontinued Operations - Summa
Discontinued Operations - Summary Of Financial Information That Has Been Segregated From Continuing Operations (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | |||
Sep. 30, 2019 | Sep. 30, 2018 | Sep. 30, 2019 | Sep. 30, 2018 | Dec. 31, 2018 | |
Discontinued Operations: | |||||
Net income from discontinued operations | $ 117 | $ 911 | $ 46,881 | $ 4,176 | |
Consumer and Industrial Chemistry Technologies | Discontinued Operations, Held-for-sale | |||||
Discontinued Operations: | |||||
Revenue | 0 | 17,280 | 11,031 | 56,267 | |
Operating expenses | 0 | (15,562) | (11,572) | (49,797) | |
Depreciation and amortization | 0 | (699) | 0 | (2,049) | |
Research and development | 0 | (161) | (69) | (483) | |
(Loss) income from operations | 0 | 858 | (610) | 3,938 | |
Other income | 0 | 59 | 35 | 251 | |
Gain on sale of business | 148 | 0 | 67,842 | 0 | |
Income before income taxes | 148 | 917 | 67,267 | 4,189 | |
Income tax expense | (31) | (6) | (20,386) | (13) | |
Net income from discontinued operations | 117 | $ 911 | 46,881 | $ 4,176 | |
Assets: | |||||
Accounts receivable, net | 0 | 0 | $ 10,547 | ||
Inventories, net | 0 | 0 | 52,069 | ||
Other current assets | 0 | 0 | 446 | ||
Property and equipment, net | 0 | 0 | 15,899 | ||
Goodwill | 0 | 0 | 19,480 | ||
Other intangible assets, net | 0 | 0 | 20,029 | ||
Assets held for sale | 0 | 0 | 118,470 | ||
Valuation allowance | 0 | 0 | 0 | ||
Assets held for sale, net | 0 | 0 | 118,470 | ||
Liabilities: | |||||
Accounts payable | 0 | 0 | 8,883 | ||
Accrued liabilities | 0 | 0 | 291 | ||
Liabilities held for sale | $ 0 | $ 0 | $ 9,174 |
Leases - Additional Disclosure
Leases - Additional Disclosures (Details) - USD ($) $ in Thousands | 9 Months Ended | |
Sep. 30, 2019 | Jan. 01, 2019 | |
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||
Operating lease, renewal term | 10 years | |
Operating lease right-of-use assets | $ 17,625 | |
Long-term operating lease liabilities | $ 17,945 | |
Accounting Standards Update 2016-02 | ||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||
Operating lease right-of-use assets | $ 18,400 | |
Long-term operating lease liabilities | $ 18,400 | |
Minimum | ||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||
Operating lease, remaining lease term | 1 year | |
Maximum | ||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||
Operating lease, remaining lease term | 19 years |
Leases - Components of Lease Ex
Leases - Components of Lease Expense and Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended |
Sep. 30, 2019 | Sep. 30, 2019 | |
Leases [Abstract] | ||
Operating lease expense | $ 652 | $ 1,958 |
Finance lease expense: | ||
Amortization of right-of-use assets | 357 | 577 |
Interest on lease liabilities | 3 | 6 |
Total finance lease expense | 360 | 583 |
Short-term lease expense | 22 | 97 |
Total lease expense | 1,034 | 2,638 |
Cash paid for amounts included in the measurement of lease liabilities: | ||
Operating cash flows from operating leases | 584 | 1,749 |
Operating cash flows from finance leases | 3 | 6 |
Financing cash flows from finance leases | $ 6 | $ 51 |
Leases - Maturities of Lease Li
Leases - Maturities of Lease Liabilities (Details) $ in Thousands | Sep. 30, 2019USD ($) |
Operating Leases | |
2019 (excluding the three months ended September 30, 2019) | $ 586 |
2020 | 2,335 |
2021 | 2,293 |
2022 | 2,257 |
2023 | 2,166 |
Thereafter | 25,695 |
Total lease payments | 35,332 |
Less: Interest | (16,678) |
Present value of lease liabilities | 18,654 |
Finance Leases | |
2019 (excluding the three months ended September 30, 2019) | 17 |
2020 | 70 |
2021 | 70 |
2022 | 46 |
2023 | 38 |
Thereafter | 22 |
Total lease payments | 263 |
Less: Interest | (43) |
Present value of lease liabilities | $ 220 |
Leases - Supplemental Balance S
Leases - Supplemental Balance Sheet Information (Details) $ in Thousands | Sep. 30, 2019USD ($) |
Operating Leases | |
Operating lease right-of-use assets | $ 17,625 |
Current portion of lease liabilities | 709 |
Long-term operating lease liabilities | 17,945 |
Total operating lease liabilities | 18,654 |
Finance Leases | |
Property and equipment | 293 |
Accumulated depreciation | (19) |
Property and equipment, net | 274 |
Current portion of lease liabilities | 48 |
Long-term finance lease liabilities | 172 |
Total finance lease liabilities | $ 220 |
Weighted Average Remaining Lease Term | |
Operating leases | 15 years 8 months 12 days |
Finance leases | 4 years 9 months 18 days |
Weighted Average Discount Rate | |
Operating leases | 8.90% |
Finance leases | 8.50% |
Revenue from Contracts with C_3
Revenue from Contracts with Customers (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2019 | Sep. 30, 2018 | Sep. 30, 2019 | Sep. 30, 2018 | |
Revenue from Contract with Customer [Abstract] | ||||
Percentage of total revenue accounted for percentage-of-completion revenue, less than | 0.10% | 0.10% | 0.10% | 0.10% |
Product sales as a percentage of total revenue | 95.00% | 95.00% | 95.00% | 95.00% |
Disaggregation of Revenue [Line Items] | ||||
Revenue | $ 21,879 | $ 53,709 | $ 99,827 | $ 134,324 |
Operating expenses (excluding depreciation and amortization): | 23,689 | 45,647 | 106,593 | 117,848 |
Products | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenue | 21,031 | 52,510 | 96,733 | 130,652 |
Operating expenses (excluding depreciation and amortization): | 23,637 | 44,048 | 105,440 | 114,365 |
Services | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenue | 848 | 1,199 | 3,094 | 3,672 |
Operating expenses (excluding depreciation and amortization): | $ 52 | $ 1,599 | $ 1,153 | $ 3,483 |
Supplemental Cash Flow Inform_3
Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands | 9 Months Ended | |
Sep. 30, 2019 | Sep. 30, 2018 | |
Supplemental cash payment information: | ||
Interest paid | $ 595 | $ 1,645 |
Income taxes paid, net of refunds | $ 887 | $ 16 |
Inventories (Details)
Inventories (Details) - USD ($) $ in Thousands | Sep. 30, 2019 | Dec. 31, 2018 |
Components of Inventory | ||
Raw materials | $ 7,339 | $ 10,608 |
Finished goods | 17,809 | 18,798 |
Inventories | 25,148 | 29,406 |
Less reserve for excess and obsolete inventory | (815) | (2,117) |
Inventories, net | $ 24,333 | $ 27,289 |
Property and Equipment - Compon
Property and Equipment - Components of Property and Equipment (Details) - USD ($) $ in Thousands | Sep. 30, 2019 | Dec. 31, 2018 |
Components of Property, Plant and Equipment | ||
Property and equipment | $ 78,764 | $ 82,462 |
Less accumulated depreciation | (37,584) | (36,977) |
Property and equipment, net | 41,180 | 45,485 |
Land | ||
Components of Property, Plant and Equipment | ||
Property and equipment | 4,372 | 4,372 |
Buildings and leasehold improvements | ||
Components of Property, Plant and Equipment | ||
Property and equipment | 37,729 | 37,719 |
Machinery and equipment | ||
Components of Property, Plant and Equipment | ||
Property and equipment | 26,871 | 26,995 |
Fixed assets in progress | ||
Components of Property, Plant and Equipment | ||
Property and equipment | 1,462 | 581 |
Furniture and fixtures | ||
Components of Property, Plant and Equipment | ||
Property and equipment | 1,670 | 1,573 |
Transportation equipment | ||
Components of Property, Plant and Equipment | ||
Property and equipment | 1,448 | 1,852 |
Computer equipment and software | ||
Components of Property, Plant and Equipment | ||
Property and equipment | $ 5,212 | $ 9,370 |
Property and Equipment - Additi
Property and Equipment - Additional Disclosures (Details) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2019 | Sep. 30, 2018 | Sep. 30, 2019 | Sep. 30, 2018 | |
Property, Plant and Equipment [Abstract] | ||||
Depreciation expense | $ 1.6 | $ 1.9 | $ 5 | $ 5.9 |
Goodwill (Details)
Goodwill (Details) - USD ($) | 3 Months Ended | 9 Months Ended | ||||
Sep. 30, 2019 | Sep. 30, 2018 | Jun. 30, 2018 | Sep. 30, 2019 | Sep. 30, 2018 | Dec. 31, 2018 | |
Goodwill [Line Items] | ||||||
Impairment of goodwill | $ 0 | $ 0 | $ 0 | $ 37,180,000 | ||
Goodwill | $ 0 | |||||
Goodwill acquired during period | $ 0 | $ 0 | ||||
Energy Chemistry Technologies | ||||||
Goodwill [Line Items] | ||||||
Impairment of goodwill | $ 37,200,000 |
Other Intangible Assets - Sched
Other Intangible Assets - Schedule of Other Intangible Assets (Details) - USD ($) $ in Thousands | Sep. 30, 2019 | Dec. 31, 2018 |
Schedule of Finite and Indefinite Lived Intangible Assets [Line Items] | ||
Finite-lived intangible assets, cost | $ 34,219 | $ 37,660 |
Finite-lived intangible assets, accumulated amortization | 13,401 | 13,593 |
Total other intangible assets | 36,979 | 40,420 |
Other intangible assets, net | 23,578 | 26,827 |
Trademarks and brand names | ||
Schedule of Finite and Indefinite Lived Intangible Assets [Line Items] | ||
Indefinite-lived intangible assets, cost | 2,760 | 2,760 |
Acquired Intangible Assets | ||
Schedule of Finite and Indefinite Lived Intangible Assets [Line Items] | ||
Finite-lived intangible assets, cost | 34,219 | 35,765 |
Finite-lived intangible assets, accumulated amortization | 13,401 | 13,097 |
Patents and technology | ||
Schedule of Finite and Indefinite Lived Intangible Assets [Line Items] | ||
Finite-lived intangible assets, cost | 16,711 | 17,399 |
Finite-lived intangible assets, accumulated amortization | 6,427 | 6,689 |
Customer lists | ||
Schedule of Finite and Indefinite Lived Intangible Assets [Line Items] | ||
Finite-lived intangible assets, cost | 15,367 | 15,367 |
Finite-lived intangible assets, accumulated amortization | 5,824 | 5,259 |
Trademarks and brand names | ||
Schedule of Finite and Indefinite Lived Intangible Assets [Line Items] | ||
Finite-lived intangible assets, cost | 1,349 | 1,385 |
Finite-lived intangible assets, accumulated amortization | 1,150 | 1,149 |
Intangible assets in progress | ||
Schedule of Finite and Indefinite Lived Intangible Assets [Line Items] | ||
Finite-lived intangible assets, cost | 792 | 1,614 |
Finite-lived intangible assets, accumulated amortization | 0 | 0 |
Deferred financing costs | ||
Schedule of Finite and Indefinite Lived Intangible Assets [Line Items] | ||
Finite-lived intangible assets, cost | 0 | 1,895 |
Finite-lived intangible assets, accumulated amortization | $ 0 | $ 496 |
Other Intangible Assets - Addit
Other Intangible Assets - Additional Disclosures (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2019 | Sep. 30, 2018 | Sep. 30, 2019 | Sep. 30, 2018 | |
Schedule of Finite and Indefinite Lived Intangible Assets [Line Items] | ||||
Amortization of finite-lived intangible assets | $ 500 | $ 300 | $ 1,500 | $ 1,000 |
Amortization of deferred financing costs | $ 0 | $ 100 | $ 1,428 | $ 294 |
Minimum | ||||
Schedule of Finite and Indefinite Lived Intangible Assets [Line Items] | ||||
Amortization period | 2 years | |||
Maximum | ||||
Schedule of Finite and Indefinite Lived Intangible Assets [Line Items] | ||||
Amortization period | 20 years |
Long-Term Debt and Credit Fac_3
Long-Term Debt and Credit Facility - Components of Long-term debt (Details) - USD ($) $ in Thousands | Sep. 30, 2019 | Dec. 31, 2018 |
Borrowings under revolving credit facility | ||
Long-term debt, classified as current: | ||
Borrowings under revolving credit facility | $ 0 | $ 49,731 |
Long-Term Debt and Credit Fac_4
Long-Term Debt and Credit Facility - Additional Disclosures (Details) - Credit Facility - USD ($) | Mar. 01, 2019 | May 10, 2013 |
Line of Credit | ||
Line of Credit Facility [Line Items] | ||
Maximum borrowing capacity | $ 75,000,000 | |
Letter of Credit | ||
Line of Credit Facility [Line Items] | ||
Deferred financing costs | $ 1,400,000 | |
Letter of Credit | Borrowings under revolving credit facility | ||
Line of Credit Facility [Line Items] | ||
Maximum borrowing capacity | $ 10,000,000 |
Earnings (Loss) Per Share - Add
Earnings (Loss) Per Share - Additional Disclosures (Details) - shares shares in Millions | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2019 | Sep. 30, 2018 | Sep. 30, 2019 | Sep. 30, 2018 | |
Restricted Stock Units | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
Anti-dilutive securities excluded from calculation of earnings per share (in shares) | 0.5 | 0.9 | 0.7 | 0.9 |
Fair Value Measurements - Addit
Fair Value Measurements - Additional Disclosures (Details) - USD ($) | 3 Months Ended | 9 Months Ended | ||||
Sep. 30, 2019 | Sep. 30, 2018 | Jun. 30, 2018 | Sep. 30, 2019 | Sep. 30, 2018 | Dec. 31, 2018 | |
Fair Value Disclosures [Abstract] | ||||||
Cash and cash equivalents | $ 106,994,000 | $ 106,994,000 | $ 3,044,000 | |||
Cash equivalents | 57,700,000 | 57,700,000 | 0 | |||
Interest bearing demand deposit | 45,500,000 | 45,500,000 | ||||
Cash | 3,800,000 | 3,800,000 | $ 3,000,000 | |||
Assets Measured at Fair Value on a Nonrecurring Basis [Line Items] | ||||||
Impairment of goodwill | $ 0 | $ 0 | $ 0 | $ 37,180,000 | ||
Energy Chemistry Technologies | ||||||
Assets Measured at Fair Value on a Nonrecurring Basis [Line Items] | ||||||
Impairment of goodwill | $ 37,200,000 |
Fair Value Measurements - Fair
Fair Value Measurements - Fair Value of Other Financial Instruments (Details) - USD ($) | Sep. 30, 2019 | Dec. 31, 2018 |
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items] | ||
Cash equivalents | $ 57,700,000 | $ 0 |
Interest bearing demand deposit | 45,500,000 | |
Cash | 3,800,000 | 3,000,000 |
Carrying Amount | ||
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items] | ||
Borrowings under Credit Facility | 0 | 49,731,000 |
Fair Value | ||
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items] | ||
Borrowings under Credit Facility | $ 0 | $ 49,731,000 |
Income Taxes - Reconciliation o
Income Taxes - Reconciliation of Effective Tax Rate (Details) | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2019 | Sep. 30, 2018 | Sep. 30, 2019 | Sep. 30, 2018 | |
Income Tax Disclosure [Abstract] | ||||
U.S. federal statutory tax rate | 21.00% | 21.00% | 21.00% | 21.00% |
State income taxes, net of federal benefit | 1.70% | 1.50% | 1.20% | (0.20%) |
Non-U.S. income taxed at different rates | 0.20% | 3.90% | 0.80% | 0.60% |
Reduction in tax benefit related to stock-based awards | (0.60%) | (4.90%) | (1.40%) | (1.70%) |
Non-deductible expenses | (0.70%) | (8.60%) | (0.40%) | (9.20%) |
Research and development credit (expense) | 0.20% | (3.50%) | 0.50% | 0.30% |
Increase in valuation allowance | (18.80%) | (3.40%) | (18.20%) | (33.60%) |
Other | (1.40%) | 0.00% | (0.70%) | 0.00% |
Effective income tax rate | 1.60% | 6.00% | 2.80% | (22.80%) |
Income Taxes - Narrative (Detai
Income Taxes - Narrative (Details) - USD ($) $ in Thousands | 3 Months Ended | ||
Jun. 30, 2018 | Sep. 30, 2019 | Dec. 31, 2018 | |
Income Tax Disclosure [Abstract] | |||
Valuation allowance | $ 15,500 | ||
Increase (decrease) in valuation allowance | $ 11,500 | ||
Deferred tax assets, net | $ 476 | $ 18,663 |
Common Stock - Reconciliation o
Common Stock - Reconciliation of Changes in Common Shares Issued and Additional Disclosures (Details) | Nov. 09, 2009series$ / sharesshares | Sep. 30, 2019$ / sharesshares | Dec. 31, 2018$ / sharesshares |
Stockholders' Equity, Number of Shares, Par Value and Other Disclosures [Abstract] | |||
Common stock, shares authorized (in shares) | 80,000,000 | 80,000,000 | 80,000,000 |
Common stock, par value (in dollars per share) | $ / shares | $ 0.0001 | $ 0.0001 | $ 0.0001 |
Preferred stock, shares authorized (in shares) | 100,000 | 100,000 | 100,000 |
Preferred stock, minimum number of series authorized (series) | series | 1 | ||
Preferred stock, at par value (in dollars per share) | $ / shares | $ 0.0001 | $ 0.0001 | $ 0.0001 |
Reconciliation of changes in common shares issued | |||
Shares issued at December 31, 2018 | 62,162,875 | ||
Issued as restricted stock award grants | 875,522 | ||
Shares issued at September 30, 2019 | 63,038,397 |
Common Stock - Stock Repurchase
Common Stock - Stock Repurchase Program (Details) - USD ($) | 3 Months Ended | 9 Months Ended | 43 Months Ended | |||
Sep. 30, 2019 | Sep. 30, 2018 | Sep. 30, 2019 | Sep. 30, 2018 | Dec. 31, 2018 | Jun. 30, 2015 | |
Equity, Class of Treasury Stock [Line Items] | ||||||
Stock repurchase program, remaining amount | $ 49,700,000 | $ 49,700,000 | ||||
Share Repurchase Program, June 2015 | ||||||
Equity, Class of Treasury Stock [Line Items] | ||||||
Stock repurchase program, authorized amount (up to) | $ 50,000,000 | |||||
Repurchase of common stock | $ 300,000 | |||||
Repurchase of common stock during period (in shares) | 0 | 0 | 0 | 0 |
Business Segment, Geographic _3
Business Segment, Geographic and Major Customer Information - Additional Disclosures (Details) | 9 Months Ended |
Sep. 30, 2019segment | |
Segment Reporting [Abstract] | |
Number of reportable segments (segment) | 1 |
Business Segment, Geographic _4
Business Segment, Geographic and Major Customer Information - Reportable Segments (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2019 | Sep. 30, 2018 | Sep. 30, 2019 | Sep. 30, 2018 | |
Summarized financial information regarding reportable segments | ||||
Net revenue from external customers | $ 21,879 | $ 53,709 | $ 99,827 | $ 134,324 |
Loss from operations | (11,853) | (4,080) | (39,976) | (60,446) |
Depreciation and amortization | 2,058 | 2,259 | 6,437 | 6,935 |
Capital expenditures | 1,102 | 1,163 | 1,869 | 3,794 |
Operating Segments | Energy Chemistry Technologies | ||||
Summarized financial information regarding reportable segments | ||||
Net revenue from external customers | 21,879 | 53,709 | 99,827 | 134,324 |
Loss from operations | (5,984) | 3,921 | (18,968) | (34,176) |
Depreciation and amortization | 1,870 | 1,734 | 5,588 | 5,300 |
Capital expenditures | 1,102 | 302 | 1,869 | 2,480 |
Corporate and Other | ||||
Summarized financial information regarding reportable segments | ||||
Net revenue from external customers | 0 | 0 | 0 | 0 |
Loss from operations | (5,869) | (8,001) | (21,008) | (26,270) |
Depreciation and amortization | 188 | 525 | 849 | 1,635 |
Capital expenditures | $ 0 | $ 861 | $ 0 | $ 1,314 |
Business Segment, Geographic _5
Business Segment, Geographic and Major Customer Information - Assets by Reportable Segments (Details) - USD ($) $ in Thousands | Sep. 30, 2019 | Dec. 31, 2018 |
Segment Reporting Information [Line Items] | ||
Total assets | $ 249,357 | $ 285,883 |
Operating Segments | Energy Chemistry Technologies | ||
Segment Reporting Information [Line Items] | ||
Total assets | 123,309 | 139,205 |
Corporate and Other | ||
Segment Reporting Information [Line Items] | ||
Total assets | 126,048 | 28,208 |
Total segments | ||
Segment Reporting Information [Line Items] | ||
Total assets | 249,357 | 167,413 |
Held for sale | ||
Segment Reporting Information [Line Items] | ||
Total assets | $ 0 | $ 118,470 |
Business Segment, Geographic _6
Business Segment, Geographic and Major Customer Information - Geographic Information (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2019 | Sep. 30, 2018 | Sep. 30, 2019 | Sep. 30, 2018 | |
Revenues from External Customers and Long-Lived Assets [Line Items] | ||||
Revenue | $ 21,879 | $ 53,709 | $ 99,827 | $ 134,324 |
U.S. | ||||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||||
Revenue | 19,663 | 35,685 | 89,653 | 108,571 |
Other countries | ||||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||||
Revenue | $ 2,216 | $ 18,024 | $ 10,174 | $ 25,753 |
Business Segment, Geographic _7
Business Segment, Geographic and Major Customer Information - Major Customers (Details) - Customer Concentration Risk - Sales | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2019 | Sep. 30, 2018 | Sep. 30, 2019 | Sep. 30, 2018 | |
Customer A | ||||
Segment Reporting Information [Line Items] | ||||
Percentage of revenue by major customers | 35.90% | 12.20% | 16.70% | 10.40% |
Customer B | ||||
Segment Reporting Information [Line Items] | ||||
Percentage of revenue by major customers | 12.30% | |||
Customer C | ||||
Segment Reporting Information [Line Items] | ||||
Percentage of revenue by major customers | 6.60% | 25.60% | 13.60% |
Commitments and Contingencies (
Commitments and Contingencies (Details) | Mar. 30, 2017lawsuit |
Punitive Lawsuits Filed in the United States District Court for the Southern District of Texas | |
Loss Contingencies [Line Items] | |
Number of lawsuits dismissed (lawsuit) | 4 |
Related Party Transaction (Deta
Related Party Transaction (Details) - USD ($) $ in Millions | 3 Months Ended | |
Sep. 30, 2019 | Jun. 30, 2019 | |
Chief Executive Officer | IRS Tax Indemnification | ||
Related Party Transaction [Line Items] | ||
Income Taxes Paid | $ 0.6 | |
Due from related party | 2.4 | |
IRS Tax Indemnification | ||
Related Party Transaction [Line Items] | ||
Loss Contingency Accrual | $ 1.8 | $ 2.4 |